A new national poll is raising alarms for Democrats as the party works to rebound from last year's election setbacks. Only 18% of voters questioned in a Quinnipiac University survey released on ...

Denote introduces an AI-powered platform that helps marketers, growth teams, and agencies build a Winning Ad Workflow. Teams can save and organize top-performing ads, analyze trends, track ad spend, ...

Jared Isaacman, a pilot and financial tech billionaire, has commanded two groundbreaking spaceflights, including leading the first private spacewalk. But his most remarkable flying has occurred over ...

WASHINGTON, Dec 17 (Reuters) - In a rare evening address from the White House, U.S. President Donald Trump boasted on Wednesday of his accomplishments and blamed his Democratic predecessor for soaring ...

With a fresh endorsement from the FDA, the last of five major drug approvals has fallen into place for GSK in 2025. Tuesday, the U.S. regulator greenlit GSK’s depemokimab, an ultra-long-acting ...

President Donald Trump’s approval rating was stagnant in one poll, improved in another and declined slightly in a third, in new polls that overlapped with his administration’s stunning capture of ...

A year ago, President Donald Trump spoke as though the American people had just delivered him a landslide for the ages. “America has given us an unprecedented and powerful mandate,” he said shortly ...

Zahi Fayad practices what he preaches. As a professor of radiology and director of the biomedical engineering and imaging institute at Mount Sinai, Fayad is leading a study investigating how our ...

HORSHAM, Pa., Dec. 17, 2025 /PRNewswire/ -- Johnson & Johnson (JNJ) announced today that the U.S. Food and Drug Administration (FDA) approved RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj), ...

President Donald Trump's triumphant assessment of his achievements in a year-end White House address to the nation offered nary a nod to the troubles now rising around him. "Over the past 11 months, ...